MEDICARE PART D COST SHARING AND SPECIALTY DRUG INITIATION IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS

被引：0
|
作者：
Doshi, J. A. [1 ]
Li, P. [1 ]
Huo, H. [1 ]
Pettit, A. R. [1 ]
Kumar, R. [1 ]
Huntington, S. F. [2 ]
Weiss, B. M. [3 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Yale Univ, New Haven, CT USA
[3] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.035
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
ME2
引用
收藏
页码：A3 / A3
页数：1
相关论文
共 50 条
  • [41] Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia
    Deenik, Wendy
    Janssen, Jeroen J. W. M.
    van der Holt, Bronno
    Verhoef, Gregor E. G.
    Smit, Willem M.
    Kersten, Marie Jose
    Daenen, Simon M. G. J.
    Verdouck, Leo F.
    Ferrant, Augustin
    Schattenberg, Anton V. M. B.
    Sonneveld, Pieter
    Kooy, Marinus van Marwijk
    Wittebol, Shulamit
    Willemze, Roelof
    Wijermans, Pierre W.
    Beverloo, H. Berna
    Lowenberg, Bob
    Valk, Peter J. M.
    Ossenkoppele, Gert J.
    Cornelissen, Jan J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (06): : 914 - 921
  • [42] EXPRESSION LEVELS OF JAK/STAT SIGNALING GENES IN NEWLY DIAGNOSED, DRUG SENSITIVE AND RESISTANT CHRONIC MYELOID LEUKEMIA PATIENTS
    Kiraz, Y.
    Saydam, G.
    Sahin, F.
    Kozanoglu, I.
    Ozdogu, H.
    Piskin, O.
    Ozcan, M. A.
    Avcu, F.
    Ural, A. U.
    Unal, A.
    Baran, Y.
    HAEMATOLOGICA, 2015, 100 : 687 - 687
  • [43] Cost Sharing for Preferred Branded Drugs in Medicare Part D
    Trish, Erin
    Blaylock, Barbara
    Van Nuys, Karen
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (13): : 1170 - 1172
  • [44] Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemia
    Ishida, Yoji
    Murai, Kazunori
    Yamaguchi, Kohei
    Miyagishima, Takuto
    Shindo, Motohiro
    Ogawa, Kazuei
    Nagashima, Takahiro
    Sato, Shinji
    Watanabe, Reiko
    Yamamoto, Satoshi
    Hirose, Takayuki
    Saitou, Souich
    Yonezumi, Masakatsu
    Kondo, Takeshi
    Kato, Yuichi
    Mochizuki, Noboru
    Ohno, Keiko
    Kishino, Satoshi
    Kubo, Kohmei
    Oyake, Tatsuo
    Ito, Shigeki
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (02) : 185 - 193
  • [45] Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia
    Masayuki Hino
    Itaru Matsumura
    Shin Fujisawa
    Kenichi Ishizawa
    Takaaki Ono
    Emiko Sakaida
    Naohiro Sekiguchi
    Yusuke Tanetsugu
    Kei Fukuhara
    Masayuki Ohkura
    Yuichiro Koide
    Naoto Takahashi
    International Journal of Hematology, 2020, 112 : 24 - 32
  • [46] Incidence of persistent/late chronic anemia in newly diagnosed patients with chronic myeloid leukemia responsive to imatinib
    Latagliata, Roberto
    Volpicelli, Paola
    Breccia, Massimo
    Vozella, Federico
    Romano, Angela
    Montagna, Chiara
    Molica, Matteo
    Finsinger, Paola
    Carmosino, Ida
    Serrao, Alessandra
    Zacheo, Irene
    Santopietro, Michelina
    Salaroli, Adriano
    Alimena, Giuliana
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (02) : 105 - 108
  • [47] Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemia
    Yoji Ishida
    Kazunori Murai
    Kohei Yamaguchi
    Takuto Miyagishima
    Motohiro Shindo
    Kazuei Ogawa
    Takahiro Nagashima
    Shinji Sato
    Reiko Watanabe
    Satoshi Yamamoto
    Takayuki Hirose
    Souich Saitou
    Masakatsu Yonezumi
    Takeshi Kondo
    Yuichi Kato
    Noboru Mochizuki
    Keiko Ohno
    Satoshi Kishino
    Kohmei Kubo
    Tatsuo Oyake
    Shigeki Ito
    European Journal of Clinical Pharmacology, 2016, 72 : 185 - 193
  • [48] Attenuated Dose Dasatinib in Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase Patients in India.
    Ahmed, Rayaz
    Singh, Reema
    Kapoor, Jyotsna
    Patra, Pritish Chandra
    Agrawal, Narendra
    Bhurani, Dinesh
    Halder, Rohan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (02): : E71 - E77
  • [49] Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia
    Hino, Masayuki
    Matsumura, Itaru
    Fujisawa, Shin
    Ishizawa, Kenichi
    Ono, Takaaki
    Sakaida, Emiko
    Sekiguchi, Naohiro
    Tanetsugu, Yusuke
    Fukuhara, Kei
    Ohkura, Masayuki
    Koide, Yuichiro
    Takahashi, Naoto
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (01) : 24 - 32
  • [50] Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
    Chen, Suning
    Zhang, Yanli
    Xu, Na
    Sun, Hui
    Li Weiming
    Yang, Yunfan
    Zhu, Zunmin
    Duan, Minghui
    Qian, Sixuan
    Zhu, Yu
    Luo, Jianmin
    Wang, Xiaodong
    Yang, Wei
    Gu, Weiying
    Li, Fei
    Liu, Bingcheng
    Xu, Yunxiao
    Liu, Zhenfang
    Wang, Chunling
    Jiang, Yirong
    Meng, Li
    Wen, Qin
    Xu, Yanli
    Zou, Xingli
    Wang, Wei
    Xue, Yan
    Xu, Hao
    Bi, Kehong
    Zhou, Fuling
    Ma, Liangming
    Fu, Rong
    Ouyang, Guifang
    Ding, Kaiyang
    Wu, Depei
    BLOOD, 2023, 142
12345